Profund Advisors’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $258K | Sell |
27,502
-10,032
| -27% | -$94.1K | 0.01% | 775 |
|
|
2025
Q1 | $267K | Sell |
37,534
-11,589
| -24% | -$82.4K | 0.01% | 740 |
|
|
2024
Q4 | $573K | Sell |
49,123
-1,229
| -2% | -$14.3K | 0.02% | 444 |
|
|
2024
Q3 | $1.03M | Buy |
50,352
+11,405
| +29% | +$234K | 0.04% | 315 |
|
|
2024
Q2 | $872K | Sell |
38,947
-9,353
| -19% | -$209K | 0.03% | 336 |
|
|
2024
Q1 | $1.33M | Sell |
48,300
-2,676
| -5% | -$73.6K | 0.05% | 277 |
|
|
2023
Q4 | $1.55M | Buy |
50,976
+10,515
| +26% | +$321K | 0.07% | 238 |
|
|
2023
Q3 | $1.28M | Buy |
40,461
+4,592
| +13% | +$145K | 0.07% | 232 |
|
|
2023
Q2 | $1.46M | Sell |
35,869
-269
| -0.7% | -$11K | 0.08% | 218 |
|
|
2023
Q1 | $1.35M | Buy |
36,138
+24,603
| +213% | +$917K | 0.08% | 215 |
|
|
2022
Q4 | $402K | Buy |
11,535
+1,458
| +14% | +$50.9K | 0.03% | 497 |
|
|
2022
Q3 | $564K | Buy |
10,077
+412
| +4% | +$23.1K | 0.04% | 356 |
|
|
2022
Q2 | $500K | Sell |
9,665
-1,021
| -10% | -$52.8K | 0.03% | 412 |
|
|
2022
Q1 | $777K | Sell |
10,686
-1,191
| -10% | -$86.6K | 0.03% | 380 |
|
|
2021
Q4 | $1.4M | Sell |
11,877
-1,221
| -9% | -$144K | 0.05% | 253 |
|
|
2021
Q3 | $1.76M | Buy |
13,098
+11,222
| +598% | +$1.51M | 0.06% | 242 |
|
|
2021
Q2 | $303K | Buy |
+1,876
| New | +$303K | 0.01% | 1054 |
|